chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patients received an expired dose; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received an expired dose) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination. No Medical History information was reported.On 09-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received an expired dose). On 09-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Patients received an expired dose) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  The vial was initially stored in the refrigerator on 08-Nov-2021.Vials did not undergo any temperature excursion. No concomitant medications were provided. No treatment medications were provided.
With my first dose, I had a blood pressure spike on day 4. When I went in for my second dose, I talked to a nurse and a pharmacist and they felt that the blood pressure spike was unrelated as they had not seen any studies indicating that as a reaction, so I went ahead and had my second shot, but my blood pressure spiked starting that night and went high enough that by the second day, as it was still quite high,  I called my provider and was given permission to increase my blood pressure medication.
Rec'd Covid vaccine 10 minutes afterwards, employee stated she felt weird in her chest, states she didn't know if it was anxiety, state pain 4/.10 offered employee to be evaluated - refused requested to sit and be monitored BP 132/72, HR 71 POX 98% repeat vs employee states chest tight refused ED eval and RRT B/P 137/77 HR 70 POX 98% still refusing ED state just wants to be monitored for a few minutes 1745 BP 140/79 HR 70 POX 98% final VS at 1751 129/77, HR 70 POX 99% Employee states she feels more comfortable now and is ready to go home. She further states she knows what to do.
Pain arches both feet, heel pain; 11AUG through present date, less severe & pain only rt arch; joint pain 3 wks, extreme weakness,arms & legs 2wks; aching severe 1 wk-1 1/2 wks; fever 2 days only 20AUG-21AUG;
Information has been received from a nurse concerning a 87 year old patient (gender not reported) who was vaccinated (date, route, dosage and site not reported) with pneumococcal 23v polysaccharide vaccine (lot# 658074/0961U). Subsequently, post vaccination, the patient experienced "severe injection site reaction". The patient did receive unspecified medical attention and improved. Additional information has been requested.
After a few hours the injected arm upper muscles ached when lifting or raised. Following day flu-like symptoms - achy, slight fever. Next day fine...on day four lost equilibrium and required medication to alleviate problem. Currently, my arm is still NOT OK when lifting or raising...somewhat incapacitating.
numbness in hand; numbness in finger; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness in hand) and HYPOAESTHESIA (numbness in finger) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included Numbness (numbness in hand numbness in finger).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (numbness in hand) and HYPOAESTHESIA (numbness in finger). At the time of the report, HYPOAESTHESIA (numbness in hand) and HYPOAESTHESIA (numbness in finger) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported No treatment information was provided
RIGHT ARM PAIN AND ARTHRALGIAS THAT STARTED 1-2 DAYS AFTER THE FIRST HEPATITIS B IMMUNIZATION. PT WENT TO A RHEUMATOLOGIST ON 8/31/2006. TREATMENT HAS BEEN HYDROXYCHLOROQUINE 200MG ONE TWICE DAILY , CELEBREX 200MG TWICE DAILY AND WELLLBUTRIN SR 100MG 4 IN THE AM. DOS 7/28-11/14/06 Complained of excruciating arthritis pain in arm of injection site. Same thing happened last month after 1st immunization. Continued with complaint on 8/16/06- DX myalgia myositis, unspecified, arthropathy unspecified. Anemia labs:
Diarrhea,n,v of 24 hrs duration; pt reported sx p/3rd inject of the series, & states retrospect noted gastrointestinal episodes p/previous injections in the series; Transient lymphocytopenia was observed;
Information has been received from a licensed practical nurse concerning a 19 year old female patient with no known pertinent medical history, and no known drug allergies reaction, who on 30-AUG-2007 on an unrelated office visit, was vaccinated with the first dose of GARDASIL.  On 29-NOV-2007, the patient was vaccinated with the second dose of GARDASIL (lot No 659055/1522U), 0.5 ml, intramuscularly.  The licensed practical nurse reported that patient did not experienced an adverse reaction after her first GARDASIL.  On 29-NOV-2007, after the patient received her second dose of GARDASIL, she experienced redness and swelling at the injection site, as well as hives, after she received her second dose of GARDASIL.  The licensed practical nurse reported that the patient had elected not to receive her third GARDASIL.  On an unknown date the patient recovered without requiring medical treatment.  Additional information has been requested.
Immediately after giving vaccines child broke out in a rash on the chest & then moved to arms. 1:1000 1mg/mL - EPI 0.2mL given rash improved within 5 minutes - Pt stayed for 20 min - rash gone & no more problems upon D/C.
Patient received the COVID Bi-valent vaccine when her intentions were to get a seasonal flu vaccine.  She developed flu-like symptoms for 2 days after receiving the COVID Vaccine.  There was miscommunication at the pharmacy between the administrator and the patient on what vaccine she was receiving.
Existing Tinnitus made significantly worse beginning one day after vaccination; Bad taste in mouth; nausea; General spacey feeling in head; weakness; slight swelling in face/neck on the side the vaccine was given, lasting for about 6 hours after the vaccination was initially administered; This is a spontaneous report from a contactable consumer (patient). A 38-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number and Expiration Date: not reported) via an unspecified route of administration, administered in right arm on 29Mar2021 at 09:45 (at the age of 38 years old) as dose number unknown, single for COVID-19 immunisation in a hospital. Medical history included eczema, prostatitis, childhood asthma, shellfish allergy- all from an unknown date; and ongoing tinnitus from 2016 (began about 5 years ago after a procedure to remove earwax with water pressure at a urgent card clinic). Prior to vaccination the patient was not diagnosed with COVID-19. There were no concomitant medications. The patient did not receive any other vaccines in 4 weeks and has no medications received in 2 weeks. On 29Mar2021, the patient experienced slight swelling in face/neck on the side the vaccine was given, lasting for about 6 hours after the vaccination was initially administered. Then on 30Mar2021 at 23:00, the patient reported that existing tinnitus became significantly worse beginning one day after vaccination. If base line was 25/100 annoying, it is now 50/100 annoying (as reported). The patient did not suffer from general hearing loss. Furthermore, on 30Mar2021 at 23:00, the patient experienced bad taste in mouth, nausea, general spacey feeling in head, and weakness. No treatment was received for the adverse events. Since vaccination, the patient has not been tested for COVID-19. The patient recovered from slight swelling in face/neck on the side the vaccine was given on an unspecified date in Mar2021 but has not recovered from the rest of the events.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Painful arm and hand 6 hrs after vaccinated. Lasted overnight into the following day. Itching started 11/2 and went away wt time. I did take ADVIL 10/30 pm.
Developed approx 2 inch swollen area at injection site. Was sore & warm to touch. Resolved without further problems.
Initial report was received from a consumer on 25 September 2009, who is also the patient. A 41-year-old female patient with no concurrent illness or past medical history who had been taking TOPAMAX concomitantly, had received an injection (route not reported) of FLUZONE SV 2009-2010, lot number U3205CA on 24 September 2009, and 4 hours later, she complained of difficulty breathing, itchy throat, mouth and tongue, lips burning, mucous discharge from both eyes, eyes reddened, muscle aches/ pain, dizziness, nausea and feeling feverish. The patient self medicated with ADVIL and 2-3 doses of BENADRYL until she went to bed. The next day, all symptoms were resolved except for a "feeling of tingling skin all over". The patient had not been evaluated by their health care provider and at the time of the report, they had not recovered. Documents held by sender: None.
Event: DVT in right leg, large volume PE.  Treatment: Admitted to Erlanger East on 10/22/21, heparin gtt initiated, continued until 10/21/21 then transitioned to Xarelto 15 mg BID for 21 days, then 20 mg daily. Outcome: pending
Date of Admission:  2/13/2022   Chief Complaint:  AMS   Source of Information:  Patient and Available medical record   History of Present Illness:  This is a 61y.o. male with past medical history of ischemic stroke of right corona radiata, Bell's palsy, and hypertension who presented to ED for concern of altered mental status.  Per patient's wife she last saw the patient at his normal at around 1330, spoke to him on the phone at 1430 without issues, and returned home around 1515 to find the patient lying on the floor in the bedroom, alert, with foam coming from his mouth.  Patient's wife denies seeing any convulsions and denies patient has history of seizures.  She proceeded to call EMS.  Per EMS record, patient found AO x1, with no obvious trauma or incontinence, no foam noted in your mouth.  Patient was unable to follow commands and was transferred to ED.  At bedside, patient is alert and oriented to himself, place and surrounding individuals-he is unable to recall events leading up to admission.
Patient had loss of consciousness after vaccination, associated with tonic clonic motions of extremities.  Complete recovery.  No prior history of seizures or adverse reactions to vaccine.  No loss of bowel or bladder control, no tongue biting
Information has been received from a 22 year old female with no pertinent medical history or drug allergies, for the Pregnancy Registry for GARDASIL, concerning herself who was vaccinated with the first (0.5ml) and second (dose not reported) dose of GARDASIL on 29-JUL-2008 and 19-SEP-2008 respectively.  There was no concomitant medication.  She became pregnant after getting the GARDASIL vaccine.  She also stated that her baby is sinking and she was having internal abnormal bleeding around her baby.  The patient's LMP was 25-OCT-2008.  The patient had a blood test.  The patient sought medical attention.  Upon internal review the internal abnormal bleeding around the baby was determined to be an other important medical event.  Additional information received indicated that the office had no knowledge of this patient having GARDASIL.  Additional information has been requested.
Information has been received from a healthcare professional referring to a patient of unknown age and gender. Information about medical history, concurrent condition and concomitant medication was unspecified. On 11-DEC-2015 the patient was inadvertently vaccinated with PNEUMOVAX 23 (lot # K007262 with expiration dated of 25-NOV-2015; strength, dosage, frequency and route unspecified) (expired product administered). No adverse effect was reported. Additional information has been requested.
Pt. was given vaccine (IM) in right upper arm. Got up and moved to a different chair to wait for his prescriptions to be filled. After 10 min he felt his head start pounding then felt severe muscle weakness from his neck, down his arms, his back, to the top of his thighs. Pt. recovered after 20 min. Went home and took ibuprofen. "Felt 99%".
Thrombocytopenia, asymptomatic. Patient was vaccinated on 12/17/2021 and routine lab draws for another condition were done on 12/23/21 and returned with platelets of 16k.
felt sick; sore arm; dose 1 of Shingrix about 6 months ago / dose 2 about 4 months ago / March 12, 2021 / diagnosed with shingles; shingles; headache; felt tingling on her cheek; had a lesion; This case was reported by a consumer via call center representative and described the occurrence of suspected vaccination failure in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included migraine and shingles.   On an unknown date, the patient received the 2nd dose of Shingrix (intramuscular) and the 1st dose of Shingrix. On 12th March 2021, between 3 and 4 months after receiving Shingrix and between 5 and 6 months after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, headache, tingling and skin lesion. On an unknown date, the patient experienced feeling unwell and pain in arm. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the vaccination failure, headache, tingling and skin lesion were unknown and the outcome of the shingles was not recovered/not resolved and the outcome of the feeling unwell and pain in arm were recovered/resolved.   It was unknown if the reporter considered the vaccination failure, shingles, headache, tingling, skin lesion, feeling unwell and pain in arm to be related to Shingrix. It was unknown if the reporter considered the vaccination failure, shingles, headache, tingling and skin lesion to be related to Shingrix.  Additional details were reported as follows: This case was reported by patient herself. The patient received 1st dose of Shingrix about 6 months before the date of reporting and dose 2 about 4 months before the date of reporting. Less than 4 months after receiving 2nd dose of Shingrix, the patient experienced a sore arm and felt sick for a few days. On 12th March 2021, the patient felt tingling on her cheek. She had a lesion and was diagnosed with shingles. This case was considered to be a suspected vaccination failure case, as the details regarding laboratory confirmation for shingles was unknown. The reporter did not consent to follow-up. For tolerance to the 1st dose of Shingrix refer linked case US2021062736 reported by same reporter; Sender's Comments:  US-GLAXOSMITHKLINE-US2021062736:same patient, same reporter
Information has been received from a 32 year old female with a history of lyme disease in 1988 who in 1969 was vaccianted with MMR vaccine. The pt reported that she received the "required doses." She stated that she was told by her doctor that her titer for MMR vaccine was low. She was not sure which titer was low, but she thought that it might be rubella. She had sought medical attention for her experience. At the time of this report, she was planning to be revaccinated. Additional info has been requested.
0.3mL vaccine given not knowing it was supposed to be diluted prior to injection. Patient is aware of the mistake. No reported abnormal symptoms after 24 hours.
Blister; Rash; This spontaneous case was reported by a health care professional and describes the occurrence of BLISTER (Blister) and RASH (Rash) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition reported.).    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, the patient experienced BLISTER (Blister) and RASH (Rash). At the time of the report, BLISTER (Blister) and RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medication were reported. Treatment medication included antibiotic ointment.   Reporter did not allow further contact
This spontaneous report as received from a other health professional refers to unspecified patients of unknown demographics. No information about medical history, drug reactions and allergies was specified. Medical assistant reported that since April 2014 GARDASIL (lot#, dose, route, strength not repored) was improperly stored and on an unknown date in approximately 2014 the patient was vaccinated with GARDASIL. No concomitant medications were reported. No adverse effects were reported. There was no product quality complaint. The outcome of is unknown. This is one of the three reports received from the same reporter (MARRS # 1409USA013208 and 1410USA004354). Additioal information has been requested.
Redness, swelling, itching. Given on 5-23-11 at 2:41 p.m.
Patient was admitted with COVID 19.  Symptoms started on 3/27, patient received the vaccine on 3/8
Employee took Moderna Covid Vaccine at 1:40 pm and at 2:00 pm, the employee was nauseated, lightheaded, hives that covered her body and had neck pain. she was sent to the ER and was given meds. Hospital staff spoke with the employee this morning and she stated that she feels ok neck pain is still there and some bumps from the hives are still present. she did say that the redness is gone and she was still taking benedryl.
Fever, myalgia, pain, induration on the local injection site, tingling sensation of fingers. Ibuprofen 400 mg every 4 hours.
Immediately following the shot, while walking to  a chair in the doctors office my daughter said her arm really hurt and she could feel the medicine running through her body.  SHe then said she felt dizzy.  Before I could get to the nurse, her head dropped and she stiffened up and had a seizure.  She was out for about 3-5 minutes.  When she awoke, she didn't remember anything but feeling dizzy.
My left arm (site of injection) was burning during the first hour after getting the vaccine (02/11/21). It was sore for the first two days. A bruise formed on day 4 and grew in size. On day 5, a body rash formed on my entire back and began radiating to both arms and neck on day 6 (which is still occurring today, 02/16/21).
devel chicken pox on 14MAY95; recv Varivax on 12MAY95;
Patient was given a 5th dose (3rd booster) of Moderna vaccine. Patient's vaccine card that was provided to the pharmacy only listed 3 doses, but when it was entered into the state registry, it was discovered the patient has already completed all recommended doses and this was an additional, unnecessary dose.
Lesions are isolated to his hands now. More on his fingers and one palm; almost looked like COVID hands; broke out into hives all over the body: elbow, chest, legs, buttocks, claves, traps (tops of back neck area) and hands; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (broke out into hives all over the body: elbow, chest, legs, buttocks, claves, traps (tops of back neck area) and hands), VACCINATION COMPLICATION (Lesions are isolated to his hands now. More on his fingers and one palm) and VACCINATION SITE REACTION (almost looked like COVID hands) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048A21A and 030M20A) for COVID-19 vaccination.     No medical history was not provided by reporter.  Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR), FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF), OMALIZUMAB (XOLAIR) and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Mar-2021, the patient experienced URTICARIA (broke out into hives all over the body: elbow, chest, legs, buttocks, claves, traps (tops of back neck area) and hands) and VACCINATION SITE REACTION (almost looked like COVID hands). On an unknown date, the patient experienced VACCINATION COMPLICATION (Lesions are isolated to his hands now. More on his fingers and one palm). The patient was treated with LEVOCETIRIZINE at an unspecified dose and frequency; TRIAMCINOLONE at an unspecified dose and frequency; DEXAMETHASONE at a dose of 4 mg and DOXYCYCLINE at an unspecified dose and frequency. At the time of the report, URTICARIA (broke out into hives all over the body: elbow, chest, legs, buttocks, claves, traps (tops of back neck area) and hands), VACCINATION COMPLICATION (Lesions are isolated to his hands now. More on his fingers and one palm) and VACCINATION SITE REACTION (almost looked like COVID hands) outcome was unknown. Not Provided          Treatment medication include levocitrazine, triamcinolone, dexamethasone, doxycycline, Zyrtec  .  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   This case was linked to MOD-2021-089538 (Patient Link).
shingles after first dose; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 80-year-old female patient who received Herpes zoster (Shingrix) (batch number 9DM72, expiry date 28th January 2023) for prophylaxis.   On 13th September 2021, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were reported as follows:  The patient received the first dose of Shingrix and had an episode of Shingles after that.  Health care professional was looking for guidance about when should the patient receive the second dose. The reporter consented to follow up.
Patient reported after the vaccination, her right arm was aching and it traveled down to her hands. Then after the pain began to move across her chest to the other arm. Patient indicated that this lasted two weeks after the flu vaccination. Then after the two weeks, her lymph node on the right side of her face began to swell up.
Second Moderna vaccine given too early. First dose given on 4/7/21; 2nd dose given on 4/29/21, 22 days after first dose.
Was given Moderna booster instead of Pfizer.  Wrong vaccine was sent from pharmacy.  Patient's parent and she agreed to take the vaccine.  Once it was given, this health care worker realized that Moderna is not approved for 16 year olds.  Parent and patient are aware of this fact now and parent asked to have this reported to VAERS.   As of this writing at 11:30 am 12/17, Patient has had only some mild body aches.  No adverse affects at this time.  She had no major reactions from her 2 doses of Pfizer.
Td was given to pt on 11/4/2002. Since then pt complains of persistent arm pain in left arm. Pt was given NSAID.
Patient complained about itching in cheek area was still talking but started to complain about tingly tongue.